PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Emerging roles of high-mobility group box-1 in liver disease

Emerging roles of high-mobility group box-1 in liver disease
2024-11-08
(Press-News.org)

Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute liver injury (ALI) caused by acetaminophen (APAP) overdose, hepatic ischemia-reperfusion injury (HIRI), and chronic conditions like nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease (ALD) are influenced by HMGB1-mediated pathways. HMGB1 is released from injured or necrotic liver cells and triggers inflammatory responses. Its circulating levels have been associated with disease severity in liver conditions, marking it as a promising biomarker and therapeutic target.

HMGB1 Structure and Functions

HMGB1 is a non-histone nuclear protein with three distinct domains responsible for DNA-binding and regulatory functions. Within the nucleus, HMGB1 aids in DNA repair, chromosomal maintenance, and cell cycle regulation. Once released extracellularly, it binds to receptors such as RAGE and TLR4, amplifying inflammatory signaling and contributing to liver damage through the activation of immune cells. Additionally, HMGB1 plays a role in autophagy, a process integral to cell survival and liver tissue regeneration.

Receptors and Signaling Pathways

HMGB1's interactions with its primary receptors, RAGE and TLR4, are essential to its role in liver disease. Upon binding, these receptors initiate pro-inflammatory signaling pathways such as the NF-κB and mitogen-activated protein kinases (MAPK) cascades, exacerbating liver inflammation and injury. These interactions also contribute to the progression of conditions like NAFLD, ALD, and liver fibrosis. Importantly, the HMGB1-RAGE axis also plays a role in hepatocellular carcinoma (HCC), influencing tumor proliferation, immune evasion, and metastasis.

Post-Translational Modifications (PTMs)

The functional diversity of HMGB1 is heavily regulated by its PTMs, including acetylation, phosphorylation, oxidation, and lactylation. These modifications control the release, localization, and activity of HMGB1, impacting its role in liver disease. For instance, acetylation of HMGB1 facilitates its translocation from the nucleus to the cytoplasm, contributing to inflammation in ALD and sepsis. Phosphorylation similarly aids in HMGB1's extracellular release, while oxidation alters its interactions with receptors, enhancing fibrotic processes and tumor cell migration. A novel PTM, lactylation, has been linked to macrophage activation in HIRI, further expanding the understanding of HMGB1's regulatory mechanisms.

Roles of HMGB1 in Acute Liver Diseases

In acute liver diseases like APAP-induced liver injury, HMGB1 serves as a key mediator of immune responses, promoting the recruitment of neutrophils and macrophages, which exacerbate liver damage. The HMGB1-TLR4 signaling pathway has been particularly implicated in the inflammatory cascades following liver injury. Therapeutic strategies targeting HMGB1, such as monoclonal antibodies and inhibitors of its release, have shown promise in reducing liver damage in animal models. Similarly, in HIRI, inhibiting HMGB1 release has been effective in mitigating liver damage and inflammation, emphasizing its potential as a therapeutic target.

Roles of HMGB1 in Chronic Liver Diseases

In chronic liver diseases like NAFLD and ALD, HMGB1 plays dual roles depending on its cellular localization. Extracellular HMGB1 promotes inflammatory pathways that accelerate the progression from simple steatosis to more severe forms like nonalcoholic steatohepatitis (NASH). Intracellularly, HMGB1 appears to protect against lipotoxicity by maintaining endoplasmic reticulum (ER) homeostasis. Additionally, in liver fibrosis, HMGB1 activates hepatic stellate cells (HSCs), contributing to the fibrotic response, while its modulation of immune responses through macrophage polarization further exacerbates fibrosis.

Therapeutic Potential

Given HMGB1’s critical involvement in liver disease pathogenesis, therapeutic strategies aimed at modulating its release, function, or receptor interactions have gained interest. Anti-HMGB1 antibodies, small-molecule inhibitors, and natural compounds like curcumin and glycyrrhizin show potential in alleviating liver inflammation and fibrosis. Furthermore, targeting specific PTMs of HMGB1, such as acetylation and lactylation, offers new avenues for therapeutic interventions, particularly in treating liver fibrosis and HCC.

Conclusions

HMGB1 is an integral player in liver disease, influencing both inflammatory and fibrotic pathways. Its roles in acute liver injury, chronic conditions, and liver cancer make it a valuable diagnostic and therapeutic target. Ongoing research into HMGB1's signaling mechanisms, PTMs, and receptor interactions promises to yield new treatments for liver diseases. However, further clinical studies are needed to fully realize the therapeutic potential of targeting HMGB1.

 

Full text

https://www.xiahepublishing.com/2310-8819/JCTH-2024-00317

 

The study was recently published in the Journal of Clinical and Translational Hepatology.

The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

END


[Attachments] See images for this press release:
Emerging roles of high-mobility group box-1 in liver disease Emerging roles of high-mobility group box-1 in liver disease 2

ELSE PRESS RELEASES FROM THIS DATE:

Exploring the systematic anticancer mechanism in selected medicinal plants

2024-11-08
Cancer remains one of the leading global causes of mortality, with an estimated increase in cases due to lifestyle, environmental, and genetic factors. Despite advancements in treatment, cancer's complexity and the side effects of conventional therapies necessitate alternative approaches. Medicinal plants, long valued for their therapeutic properties, have shown promise in cancer treatment, attributed to their natural phytoconstituents. This review focuses on the anticancer mechanisms of specific medicinal plants and discusses their potential for future therapeutic development. Anticancer Mechanisms of Selected Medicinal Plants Medicinal plants exert anticancer ...

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials
2024-11-08
The University of Cincinnati’s Yasmin Aziz, MD, and Joseph Broderick, MD, coauthored an editorial published Nov. 7 in the journal Neurology analyzing the current use and potential future of alternatives to traditional informed consent in acute stroke trials.    Patient informed consent is a crucial part of ethical clinical trial design and implementation, but time is of the essence for stroke trials. Approximately 2 million neurons die each minute they are deprived of oxygen, and patients are also sometimes incapacitated and therefore unable to consent ...

Scarlet Macaw parents ‘play favorites,’ purposefully neglect younger chicks

2024-11-08
Scarlet macaws are a symbol of fidelity and virtue to many people because they are thought to mate for life — but it turns out that they also “play favorites” when feeding their young, making them excellent mates, but neglectful parents. Fortunately, Texas A&M scientists have developed a way to ensure the birds’ bad parenting results in fewer chick deaths.   Researchers at the College of Veterinary Medicine and Biomedical Sciences have discovered that scarlet macaws purposefully neglect feeding the youngest chicks ...

One gene provides diagnoses for 30 patients whose condition was unexplained for years

2024-11-08
An international team of researchers has provided a genetic diagnosis for 30 individuals whose condition was undiagnosed for years despite extensive clinical or genetic testing. The study, conducted by researchers at Baylor College of Medicine, National University of Singapore and collaborating institutions worldwide, appeared in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics. “The story of our findings began with one patient I saw in the clinic presenting an uncommon combination of problems,” said first and co-corresponding ...

Current practice and emerging endoscopic technology in the diagnosis of colorectal cancer

2024-11-08
The evolution of gastrointestinal (GI) endoscopy has transformed CRC diagnostics since its early 20th-century origins. Initial rigid endoscopes provided limited visualization, were highly uncomfortable for patients, and only partially visualized the colon. With the introduction of fiber-optic technology in the 1950s, endoscopy began transmitting real-time images, greatly enhancing diagnostic applications for GI conditions. Today, CRC remains a primary target for endoscopic screening due to its high prevalence as the second leading cause of cancer ...

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders
2024-11-08
Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver disease (ALD), and hepatitis C virus infection. These conditions are closely tied to hepatic steatosis, a condition characterized by the abnormal accumulation of fat in the liver. Recent genome-wide association studies have identified the 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) gene and its loss-of-function variant ...

Key pathway leading to neurodegeneration in early stages of ALS identified

Key pathway leading to neurodegeneration in early stages of ALS identified
2024-11-08
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for Disease Control and Prevention. The rapidly progressing neurodegenerative disease causes the death of neurons in the brain and spinal cord, resulting in muscle weakness, respiratory failure and dementia. Despite the devastating nature of the disease, little is known about what first triggers the deterioration of motor neurons at the onset of ALS. Now, researchers from University of California San Diego and their colleagues ...

Ferroptosis in regulating treatment tolerance of digestive system tumors

Ferroptosis in regulating treatment tolerance of digestive system tumors
2024-11-08
The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant tumors worldwide. Despite advancements in endoscopic diagnostic methods, which enable earlier detection and treatment, a large portion of patients still receive diagnoses at later stages. For these patients, chemotherapy, radiation, and immunotherapies are often the only viable options, yet resistance to treatment remains common, leading to high recurrence and mortality rates. Research increasingly shows that ferroptosis may be a key mechanism to reverse treatment tolerance. Ferroptosis, characterized by ...

A promising future in pancreatic incidentaloma detection

A promising future in pancreatic incidentaloma detection
2024-11-08
In recent research published in eGastroenterology, Dr. J-Matthias Löhr and colleagues provide an in-depth review of diagnostic methods for pancreatic incidentaloma—incidental findings often detected during imaging scans intended for other conditions. These pancreatic lesions, which vary in severity, can occasionally signal pancreatic cancer in its earliest stages. However, traditional methods, including MRI and CT scans, are limited by invasiveness, cost, and variable sensitivity to early pancreatic changes. The research highlights ...

Stabilizing lithium-ion batteries: The vanadium touch

Stabilizing lithium-ion batteries: The vanadium touch
2024-11-08
As demand surges for electric vehicles and energy storage systems, lithium-ion batteries need to deliver higher energy densities at lower costs. While conventional cathode materials like LiFePO4 and Li-Ni-Co-Mn-O are widely used, they often fail to balance performance with affordability. Lithium-rich manganese oxides (LRMOs) have emerged as a potential alternative due to their high capacity and cobalt-free composition. However, their low initial Coulombic efficiency and rapid voltage decay have limited their broader application. Addressing these challenges requires deeper research to stabilize LRMOs for widespread commercial use. In September, 2024, a team from Guangdong University of Technology, ...

LAST 30 PRESS RELEASES:

Chemists create world’s thinnest spaghetti

Empowering neuroscience: Large open brain models released

From traditional to technological: Advancements in fresco conservation

Design and imagination as essential tools during the climate crisis

Innovating archaeology: HKU scholars utilize immersive 3D tech to document and study the human past

What's the story, morning glory?

The unsolved mystery sounds of the Southern Ocean #ASA187

These wild chimpanzees play as adults to better cooperate as a group

Physical activity and all-cause mortality by age in 4 multinational megacohorts

Prenatal diet and infant growth from birth to age 24 months

Obesity prevention at an early age

New method for designing artificial proteins

MSU expert: How AI can help people understand research and increase trust in science

​​​​​​​Urgent need to enable more farmers and contractors to revive England’s network of hedgerows

ASH inclusion program retained and engaged hematologists underrepresented in field, 20-year analysis shows

How anti-obesity drugs are linked to food waste

Discovery explains kidney damage caused by blood pressure drugs

NYU Langone performs world’s first fully robotic double lung transplant

APSS accepting sleep and circadian research abstracts and session proposals for SLEEP 2025 in Seattle

DNA repair: A look inside the cell’s ‘repair café’

Astronomers take the first close-up picture of a star outside our galaxy

Here’s something Americans agree on: Sports build character

Engineering nature’s blueprint: Dendron-based assemblies for chlorophyll’s materials

Study reveals how cell types shape human brain networks

New genetic explanation for heart condition revealed

Poor mental health linked to browsing negative content online

People with migraine at high risk of depression during pandemic

Climate-driven hazards increases risk for millions of coastal residents, study finds

Females sleep less, awaken more frequently than males

Most Americans want primary care providers to address mental health

[Press-News.org] Emerging roles of high-mobility group box-1 in liver disease